November 20th 2025, 6:00pm
After surviving testicular cancer, I feel like I was given a second chance at life. Although given challenges, I have learned to be resilient and face adversity head-on.
November 20th 2025, 5:00pm
Dr. Ajay Gupta sat down with CURE to explain the basics of gastrointestinal stromal tumors, highlighting what patients with this disease need to know.
November 20th 2025, 4:00pm
The FDA accepted a new drug application for zidesamtinib for previously treated locally advanced or metastatic ROS1-positive non-small cell lung cancer.
November 20th 2025, 2:00pm
Dr. Michael Staehler highlighted nutrition’s role in kidney cancer, noting that diet, stress management, and lifestyle can impact outcomes and well-being.
November 19th 2025, 10:00pm
I reflect on my brain tumor journey, sharing how gratitude, love and connection with my parents and others strengthened me through difficult times.
November 19th 2025, 8:32pm
The FDA has approved Hyrnuo for some with locally advanced or metastatic non-squamous non–small cell lung cancer with activating mutations.
November 19th 2025, 8:24pm
The FDA approved Imdelltra after a study showed longer survival compared with chemotherapy in advanced small cell lung cancer.
November 19th 2025, 6:00pm
I never dreamed a stranger could teach me so much about cancer, life and living with gratitude but I'm so glad she did!
November 19th 2025, 5:00pm
Dr. Jorge E. Cortes discussed the evolution of chronic myeloid leukemia treatment and emerging strategies aimed at improving outcomes and quality of life.
November 19th 2025, 4:00pm
The oral therapy DPTX3186 received fast track status to help speed development of a potential new option for patients with gastric cancer.
Advice From a Cancer Survivor: Be Thankful
Breaking Down Gastrointestinal Stromal Tumor Basics
FDA Accepts NDA for Zidesamtinib in Previously Treated ROS1+ NSCLC
Understanding the Role of Nutrition in Kidney Cancer Care